Laura Milliken is a Manchester, Connecticut based nurse practitioner. Active license number of Laura Milliken is 001929 in Connecticut. Her current practice location is 935 Main St, Manchester. Patients can reach her at 860-646-0670 or can fax her at 860-643-9388. Laura Milliken is APRN and her NPI number (Unique professional ID assigned by NPPES) is 1437266079. Laura Milliken has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Laura Milliken speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1437266079
NPI Enumeration Date:
23 Aug, 2006
NPI Last Update On:
15 Nov, 2007
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Laura Milliken are as mentioned below.
License Number
Specialization
State
Status
001929
Connecticut
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Laura Milliken 935 Main St, Watkins Centre Manchester, Connecticut
Zip:
06040-6059
Phone Number:
860-646-0670
Fax Number:
860-643-9388
Patients can reach Laura Milliken at 935 Main St, Manchester, Connecticut or can call to book an appointment on 860-646-0670.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.